Novolin L | |
Lente by Novo Nordisk | |
intermediate-acting | r-DNA/GE/GM |
U100 | Zinc |
Line | Novolin |
Also known as | Monotard |
Similar to | |
Action in cats |
|
Action in dogs |
|
Use and Handling | |
---|---|
Type | cloudy |
Shelf Life | 24 months |
When opened | 28 days |
In pen | N/A |
Notes |
|
A U100 r-DNA/GE/GM lente, intermediate-length, lente insulin made by Novo Nordisk and sold by this brand name in North America until the end of 2003[2][3]. Novo's name for the same insulin elsewhere was Monotard[4][5][6][7].
The insulin was also comparable to Eli Lilly's Humulin L[8][9][10].
What Lente Is Not[]
No Lente-type insulin regardless of species can contain any NPH/isophane insulin[11] or any R/Neutral insulin[12][13].
Both are chemically impossible: the phenol preservative present in NPH/isophane alters the action of Lente-type insulins, creating a mixture with an approximate action of R/Neutral[14].
The zinc suspension of Lente-type insulin binds R/Neutral, causing the short-acting insulin to slow, losing its short-acting effect[15][16][17][18].
Combining Lente Family Insulins[]
Insulin manufacturers[19] indicate that R/neutral and semilente, Lente, ultralente insulins are able to be combined in the same syringe, but only just before injection. In pre-filled syringes, the zinc suspension of the Lente-type insulins binds the R/neutral, causing it to lose its short-acting effect. Various studies have documented this, and some doctors advise against using R/neutral in the same syringe with the Lente family of insulins[20][21][22][23].
None of the Lente family of insulins (semilente, Lente, Ultralente) can be combined with[24] NPH/isophane insulins. The phenol preservatives present in NPH-type insulins alters the Lente-types to the point where they become a close approximation of R/neutral, with regard to action[25]. Keeping the phenol preservatives in mind, all protamine-suspended insulin mixes would be "off limits" regarding same syringe mixing with any Lente-type insulins[26]. |
The Novo insulins, Monotard and Ultratard, were available slightly longer in Europe.
From the announcement: Monotard and Ultratard will not be available in the UK after February 2006. The discontinuation of these insulins was initially announced in September 2004. Initially the discontinuation was scheduled for February 2006, however this date has now been brought forward to October 2005.
Further Reading[]
- Converting a Diabetic Pet from a Human Lente Insulin Preparation to Caninsulin
- No More Humulin Lente-What Do We Use?
See also Substitutes_for_Humulin_U_and_L.
References[]
- ↑ Insulins-North American Veterinary Conference-2005
- ↑ Photo of Novolin L vial and carton
- ↑ US-FDA Novolin L Discontinuation Notice October 2003
- ↑ Prescribing Novo Insulins
- ↑ EMEA Scientific Discussion-Monotard
- ↑ Lilly EU/UK Product Sheet & Time Activity Profiles
- ↑ Monotard/Ultratard Discontinuation Notice July 2005
- ↑ Humulin L, etc.-Lente Human Insulin Remedyfind.com
- ↑ US-FDA-Humulin L Discontinuation Notice-July 2005
- ↑ Humulin L Discontinuation Notice-July 2004
- ↑ Combining Lente-type Insulins with Phenol-Preserved Insulins
- ↑ Lente Zinc Suspension Causes Loss Of R/Neutral Short-Acting Effect
- ↑ Availability of Soluble (R/Neutral) Insulin in Mixed Preparations of Crystalline (Lente) & Ultralente GE Insulins-Clinical Therapeutics-1991
- ↑ Lente-Type Insulins & NPH/Isophane Insulins-A Bad Combination
- ↑ Intermediate-Acting Insulin Preparations: NPH (Isophane) & Lente Diabetes Care-1980
Note: in 1980 there was only beef Lente-type insulin-no pork or R-DNA/GE/GM Lente insulins - ↑ Absorption Kinetics & Action Profiles-Single Subcutaneous Administration of Human Soluble (R/Neutral) & Lente Insulin-Diabetes Care-1987
- ↑ Delayed Onset of Action of Soluble (R/Neutral) Insulin After Premixing With Lente Insulin Diabetes Research & Clinical Practice-1983
- ↑ Resource Guide 2005-American Diabetes Association
- ↑ Insulin Producers vs Doctors Re:Combining R/Neutral & Lente-type Insulins
- ↑ Availability of Soluble (R/Neutral) Insulin in Mixed Preparations of Crystalline (Lente) & Ultralente GE Insulins-Clinical Therapeutics-1991
- ↑ Absorption Kinetics & Action Profiles-Single Subcutaneous Administration of Human Soluble (R/Neutral) & Lente Insulin-Diabetes Care-1987
- ↑ Delayed Onset of Action of Soluble (R/Neutral) Insulin After Premixing With Lente Insulin Diabetes Research & Clinical Practice-1983
- ↑ RxEd.org-Insulin Therapy-Mixing Precautions
- ↑ Phenol Preservatives & Lente-type Insulins--A Bad Combination
- ↑ RxEd.org-Insulin Therapy-Mixing Precautions
- ↑ RxEd.org-Insulin Therapy-Mixing Precautions